Advertisement
Screener

PRECIGEN, INC. (PGEN) Other Noncash Income (Expense)

PRECIGEN, INC. Other Noncash Income (Expense)

PRECIGEN, INC. (PGEN) reported Other Noncash Income (Expense) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OtherNoncashIncomeExpense · last filed 2026-03-25

  • PRECIGEN, INC. other noncash income (expense) for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • PRECIGEN, INC. other noncash income (expense) for the quarter ending 2023-12-31 was $1.00K.
  • PRECIGEN, INC. other noncash income (expense) for the quarter ending 2023-09-30 was -$2.00K.
  • PRECIGEN, INC. other noncash income (expense) for the quarter ending 2022-12-31 was -$2.00K.
  • PRECIGEN, INC. other noncash income (expense) for fiscal 2025 was $0.00.
  • PRECIGEN, INC. other noncash income (expense) for fiscal 2024 was $0.00.
  • PRECIGEN, INC. other noncash income (expense) for fiscal 2023 was -$2.00K.
  • PRECIGEN, INC. other noncash income (expense) for fiscal 2022 was -$107.00K.
Period endOther Noncash Income (Expense) 3 monthOther Noncash Income (Expense) 3 month as first filedOther Noncash Income (Expense) 6 monthOther Noncash Income (Expense) 6 month as first filedOther Noncash Income (Expense) 9 monthOther Noncash Income (Expense) 9 month as first filedOther Noncash Income (Expense) 12 monthOther Noncash Income (Expense) 12 month as first filed
2025-12-31$0.00
10-K · filed 2026-03-25
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$0.00
10-K · filed 2026-03-25
2024-09-30$0.00
10-Q · filed 2024-11-14
2023-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$1.00K
derived: sum of 2 quarters · filed 2026-03-25
-$2.00K
10-K · filed 2026-03-25
2023-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$3.00K
10-Q · filed 2024-11-14
2023-06-30-$1.00K
10-Q · filed 2023-08-09
2022-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
-$2.00K
derived: sum of 2 quarters · filed 2025-03-19
-$107.00K
derived: sum of 3 quarters · filed 2025-03-19
-$107.00K
10-K · filed 2025-03-19
-$106.00K
10-K · filed 2023-03-06
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$105.00K
derived: sum of 2 quarters · filed 2023-11-09
-$105.00K
10-Q · filed 2023-11-09
-$129.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-06-30-$105.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$105.00K
10-Q · filed 2023-08-09
-$129.00K
derived: sum of 3 quarters · filed 2024-03-19
-$128.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-03-31$0.00
10-Q · filed 2022-05-09
-$24.00K
derived: sum of 2 quarters · filed 2024-03-19
-$23.00K
derived: sum of 3 quarters · filed 2024-03-19
-$23.00K
derived: sum of 4 quarters · filed 2024-03-19
2021-12-31-$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
-$23.00K
derived: sum of 2 quarters · filed 2024-03-19
-$23.00K
derived: sum of 3 quarters · filed 2024-03-19
-$24.00K
10-K · filed 2024-03-19
2021-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$1.00K
derived: sum of 2 quarters · filed 2022-11-09
$0.00
10-Q · filed 2022-11-09
$4.60M
10-Q · filed 2021-11-08
$73.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$1.00K
10-Q · filed 2022-08-08
$4.60M
10-Q · filed 2021-08-09
$72.00K
derived: sum of 3 quarters · filed 2023-03-06
-$148.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31-$1.00K
10-Q · filed 2022-05-09
$4.60M
10-Q · filed 2021-05-10
$72.00K
derived: sum of 2 quarters · filed 2023-03-06
-$148.00K
derived: sum of 3 quarters · filed 2023-03-06
$203.00K
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31$73.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
-$147.00K
derived: sum of 2 quarters · filed 2023-03-06
$204.00K
derived: sum of 3 quarters · filed 2023-03-06
-$35.00K
10-K · filed 2023-03-06
-$226.00K
10-K · filed 2021-03-01
2020-09-30-$220.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$131.00K
derived: sum of 2 quarters · filed 2021-11-08
-$108.00K
10-Q · filed 2021-11-08
$2.30M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$351.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$112.00K
10-Q · filed 2021-08-09
$2.52M
derived: sum of 3 quarters · filed 2022-03-01
$2.42M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$239.00K
10-Q · filed 2021-05-10
$2.17M
derived: sum of 2 quarters · filed 2022-03-01
$2.06M
derived: sum of 3 quarters · filed 2022-03-01
-$841.00K
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$2.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$2.30M
derived: sum of 2 quarters · filed 2022-03-01
-$602.00K
derived: sum of 3 quarters · filed 2022-03-01
-$837.00K
10-K · filed 2022-03-01
2019-09-30-$105.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$3.01M
derived: sum of 2 quarters · filed 2020-11-09
-$3.25M
10-Q · filed 2020-11-09
-$3.28M
10-Q · filed 2019-11-12
-$3.70M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30-$2.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$3.14M
10-Q · filed 2020-08-10
-$3.17M
10-Q · filed 2019-08-09
-$3.60M
derived: sum of 3 quarters · filed 2021-03-01
-$4.03M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31-$235.00K
10-Q · filed 2020-05-11
-$247.00K
10-Q · filed 2019-05-09
-$693.00K
derived: sum of 2 quarters · filed 2021-03-01
-$1.12M
derived: sum of 3 quarters · filed 2021-03-01
-$1.20M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$458.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$888.00K
derived: sum of 2 quarters · filed 2021-03-01
-$966.00K
derived: sum of 3 quarters · filed 2021-03-01
-$1.09M
10-K · filed 2021-03-01
2018-09-30-$430.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$508.00K
derived: sum of 2 quarters · filed 2019-11-12
-$635.00K
10-Q · filed 2019-11-12
-$1.97M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30-$78.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$205.00K
10-Q · filed 2019-08-09
-$1.54M
derived: sum of 3 quarters · filed 2020-03-02
-$3.29M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$127.00K
10-Q · filed 2019-05-09
-$1.46M
derived: sum of 2 quarters · filed 2020-03-02
-$3.22M
derived: sum of 3 quarters · filed 2020-03-02
$244.00K
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$3.09M
derived: sum of 2 quarters · filed 2020-03-02
$371.00K
derived: sum of 3 quarters · filed 2020-03-02
$517.00K
10-K · filed 2020-03-02
2017-09-30-$1.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$1.70M
derived: sum of 2 quarters · filed 2018-11-08
$1.85M
10-Q · filed 2018-11-08
$1.45M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$3.46M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13
$3.61M
10-Q · filed 2018-08-13
$3.20M
derived: sum of 3 quarters · filed 2019-03-01
$2.33M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$146.00K
10-Q/A · filed 2018-08-13
-$257.00K
derived: sum of 2 quarters · filed 2019-03-01
-$1.13M
derived: sum of 3 quarters · filed 2019-03-01
-$1.32M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$403.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$1.27M
derived: sum of 2 quarters · filed 2019-03-01
-$1.47M
derived: sum of 3 quarters · filed 2019-03-01
-$1.66M
10-K · filed 2019-03-01
2016-09-30-$868.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$1.07M
derived: sum of 2 quarters · filed 2017-11-09
-$1.26M
10-Q · filed 2017-11-09
-$1.41M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30-$198.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$391.00K
10-Q · filed 2017-08-09
-$546.00K
derived: sum of 3 quarters · filed 2018-03-01
-$309.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31-$193.00K
10-Q · filed 2017-05-10
-$348.00K
derived: sum of 2 quarters · filed 2018-03-01
-$111.00K
derived: sum of 3 quarters · filed 2018-03-01
-$389.00K
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$155.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$82.00K
derived: sum of 2 quarters · filed 2018-03-01
-$196.00K
derived: sum of 3 quarters · filed 2018-03-01
-$460.00K
10-K · filed 2018-03-01
2015-09-30$237.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$41.00K
derived: sum of 2 quarters · filed 2016-11-09
-$305.00K
10-Q · filed 2016-11-09
-$784.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30-$278.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$542.00K
10-Q · filed 2016-08-09
-$1.02M
derived: sum of 3 quarters · filed 2017-03-01
-$1.19M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$264.00K
10-Q · filed 2016-05-10
-$743.00K
derived: sum of 2 quarters · filed 2017-03-01
-$916.00K
derived: sum of 3 quarters · filed 2017-03-01
-$952.00K
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$479.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$652.00K
derived: sum of 2 quarters · filed 2017-03-01
-$688.00K
derived: sum of 3 quarters · filed 2017-03-01
-$723.00K
10-K · filed 2017-03-01
2014-09-30-$173.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$209.00K
derived: sum of 2 quarters · filed 2015-11-09
-$244.00K
10-Q · filed 2015-11-09
-$169.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$36.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
-$71.00K
10-Q · filed 2015-08-10
$4.00K
derived: sum of 3 quarters · filed 2016-02-29
2014-03-31-$35.00K
10-Q · filed 2015-05-11
-$42.00K
10-Q · filed 2014-05-09
$40.00K
derived: sum of 2 quarters · filed 2016-02-29
2013-12-31$75.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$75.00K
10-K · filed 2016-02-29
2013-09-30$0.00
10-Q · filed 2014-11-13
2013-03-31-$3.00K
10-Q · filed 2014-05-09
2012-12-31$0.00
10-K · filed 2015-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Immunome Inc. (IMNM)United States$2.538B-9.45
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67